Categories: News

Touareg Group Technologies Co. Launches with USD 1 Billion Capital to Power TrustglobeX — A New Era for Global Crypto Exchange

NEW YORK, Nov. 20, 2025 /PRNewswire/ — Global investment and fintech powerhouse Touareg Group has announced the official launch of Touareg Group Technologies Co., capitalized with a paid-up fund of USD 1 billion. At the heart of this milestone is TrustglobeX, the Group’s flagship crypto exchange set to redefine the global digital-asset industry through unmatched liquidity, cutting-edge infrastructure, and a bold international vision.

- Advertisement -

TrustglobeX represents the cornerstone of Touareg Group’s expansion into the digital-finance frontier. Designed for both institutional and retail markets, the exchange combines deep-liquidity architecture with lightning-fast transaction speeds and a multi-chain trading environment. Its hybrid wallet system delivers instant accessibility alongside top-tier security, while its advanced analytics and intelligent order-execution engine give traders a decisive edge in fast-moving markets.

- Advertisement -

Chris Martin, Head of Financial and Strategic Investor Group at Touareg Group, described TrustglobeX as “the financial engine of a new digital economy,” emphasizing that the platform is backed by tangible capital strength and long-term commitment rather than speculation.

- Advertisement -

“This USD 1 billion investment is not symbolic — it represents our absolute determination to build a serious, world-class crypto exchange that can stand among the global leaders for decades to come,” Martin said. “Touareg Group is entering this arena with conviction, discipline, and a vision to shape the future of digital finance.”

- Advertisement -

With its billion-dollar foundation, Touareg Group Technologies Co. is setting a new benchmark for financial strength and credibility in the crypto sector. The company plans to expand TrustglobeX across Asia, the Middle East, and Europe through regional hubs that connect liquidity, foster innovation, and serve millions of users worldwide. Analysts already view TrustglobeX as one of 2025’s most anticipated global launches — a platform built not only for today’s traders but for the next generation of digital-asset pioneers.

- Advertisement -

From its financial power to its unwavering vision, TrustglobeX embodies Touareg Group’s philosophy of “Trust Without Borders,” signaling a bold step toward a smarter, faster, and more connected world of finance.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2826356/image.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/touareg-group-technologies-co-launches-with-usd-1-billion-capital-to-power-trustglobex–a-new-era-for-global-crypto-exchange-302619500.html

- Advertisement -

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

5 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

5 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

5 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

5 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

5 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

5 hours ago